BRIEF published on 11/05/2024 at 19:25, 15 days 15 hours ago CannaPharmaRx Advances with New Cannabis Shipment to Israel Revenue Growth International Expansion CannapharmaRx Cannabis Shipment Israel Market
PRESS RELEASE published on 11/05/2024 at 19:20, 15 days 15 hours ago CannapharmaRx to Complete Additional Shipment in November CannaPharmaRX, Inc. reports continued progress at its cannabis facility in Cremona, Alberta. Recent shipments to Israel show growth potential. Expansion plans in Europe and globally Global Expansion Revenue Growth CannapharmaRx Cannabis Production Shipments To Israel
BRIEF published on 08/15/2024 at 19:00, 3 months 5 days ago CannaPharmaRx Receives Multiple Purchase Orders and Begins Delivery of Product International Expansion Medical Cannabis CannapharmaRx Cannabis Production Purchase Orders
PRESS RELEASE published on 08/15/2024 at 18:55, 3 months 5 days ago CannaPharmaRx Receives Multiple Purchase Orders and Begins Delivery of Product CannaPharmaRx, Inc. receives 600KG cannabis orders from Cantek Holdings, further solidifying its position in the cannabis market internationally. Continues high-quality production at Cremona facility International Markets CannapharmaRx Cantek Holdings Cannabis Orders Cremona Facility
BRIEF published on 06/28/2024 at 09:05, 4 months 23 days ago CannaPharmaRx Reports Q1 2024 Financial Performance Financial Results Revenue Operating Expenses Licenses Strategic Agreements
PRESS RELEASE published on 06/28/2024 at 09:00, 4 months 23 days ago Q1 2024 Financial Results CannaPharmaRx reports Q1 2024 financial results with revenue commencing. The company anticipates accelerated growth, international expansion, and strategic partnerships Financial Results Revenue Growth Q1 2024 CannapharmaRx
BRIEF published on 05/20/2024 at 19:50, 6 months ago CannaPharmaRx to Host Investor Conference Call on May 21, 2024 Investor Conference Call Financial Update Cannabis Production Dean Medwid
PRESS RELEASE published on 05/20/2024 at 19:45, 6 months ago CORRECTION FROM SOURCE: CannaPharmaRx to Host Investor Conference Call CannaPharmaRx, Inc. (OTC PINK:CPMD) will host an investor conference call on May 21, 2024, at 1PM Eastern time to provide updates on financials, products, distribution, and expansion Investor Conference Call Financial Update CannapharmaRx Cannabis Production CPMD
BRIEF published on 05/20/2024 at 18:35, 6 months ago CannaPharmaRx to Host Investor Conference Call Investor Conference Financial Update CannapharmaRx Cannabis Production Dean Medwid
PRESS RELEASE published on 05/20/2024 at 18:30, 6 months ago CannaPharmaRx to Host Investor Conference Call CannaPharmaRx, Inc. to hold investor conference call on May 21, 2024, providing updates on financials, products, orders, and forecasts. Visit www.cannapharmarx.com for details Investor Conference Call Financial Update CannapharmaRx Cannabis Production Forecasted Revenues
Published on 11/21/2024 at 10:03, 35 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 38 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 38 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 3 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 13 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 10:04, 34 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 36 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 38 minutes ago Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 38 minutes ago Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 09:01, 1 hour 37 minutes ago Original-Research: Netfonds AG (von NuWays AG): Buy
Published on 11/21/2024 at 06:58, 3 hours 40 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 18 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 53 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 53 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo